Inside Washington: Safety, Risk, and Biotechnology Regulation

June 15, 2002
Jill Wechsler
Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

BioPharm International, BioPharm International-06-01-2002, Volume 15, Issue 6

by Jill Wechsler Concerns about product safety and stiffer FDA regulation of manufacturers may be drying up the biotech pipeline